Hemipherx's application seeks approval for use of the drug, marketed as Naturaferon in the country, in hepatitis C patients for whom recombinant interferon is no longer effective. End ...
More...
Hemipherx's application seeks approval for use of the drug, marketed as Naturaferon in the country, in hepatitis C patients for whom recombinant interferon is no longer effective. End ...
More...
There are currently 1 users browsing this thread. (0 members and 1 guests)
Bookmarks